Underlying genetic variation in familial frontotemporal dementia: sequencing of 198 patients.


Journal

Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437

Informations de publication

Date de publication:
01 2021
Historique:
received: 17 04 2020
revised: 01 06 2020
accepted: 14 07 2020
pubmed: 28 8 2020
medline: 2 9 2021
entrez: 27 8 2020
Statut: ppublish

Résumé

Frontotemporal dementia (FTD) presents with a wide variability in clinical syndromes, genetic etiologies, and underlying pathologies. Despite the discovery of pathogenic variants in several genes, many familial cases remain unsolved. In a large FTD cohort of 198 familial patients, we aimed to determine the types and frequencies of variants in genes related to FTD. Pathogenic or likely pathogenic variants were revealed in 74 (37%) patients, including 4 novel variants. The repeat expansion in C9orf72 was most common (21%), followed by variants in MAPT (6%), GRN (4.5%), and TARDBP (3.5%). Other pathogenic variants were found in VCP, TBK1, PSEN1, and a novel homozygous variant in OPTN. Furthermore, we identified 15 variants of uncertain significance, including a promising variant in TUBA4A and a frameshift in VCP, for which additional research is needed to confirm pathogenicity. The patients without identified genetic cause demonstrated a wide clinical and pathological variety. Our study contributes to the clinical characterization of the genetic subtypes and confirms the value of whole-exome sequencing in identifying novel genetic variants.

Identifiants

pubmed: 32843152
pii: S0197-4580(20)30230-X
doi: 10.1016/j.neurobiolaging.2020.07.014
pii:
doi:

Substances chimiques

Cell Cycle Proteins 0
Cytoskeletal Proteins 0
DNA-Binding Proteins 0
DNMBP protein, human 0
MAPT protein, human 0
Membrane Transport Proteins 0
OPTN protein, human 0
PSEN1 protein, human 0
Presenilin-1 0
TARDBP protein, human 0
tau Proteins 0
Protein Serine-Threonine Kinases EC 2.7.11.1
TBK1 protein, human EC 2.7.11.1
VCP protein, human EC 3.6.4.6
Valosin Containing Protein EC 3.6.4.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

148.e9-148.e16

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Auteurs

Merel O Mol (MO)

Department of Neurology & Alzheimer Center, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: m.o.mol@erasmusmc.nl.

Jeroen G J van Rooij (JGJ)

Department of Neurology & Alzheimer Center, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.

Tsz H Wong (TH)

Department of Neurology & Alzheimer Center, Erasmus Medical Center, Rotterdam, the Netherlands.

Shamiram Melhem (S)

Department of Neurology & Alzheimer Center, Erasmus Medical Center, Rotterdam, the Netherlands.

Annemieke J M H Verkerk (AJMH)

Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.

Anneke J A Kievit (AJA)

Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.

Rick van Minkelen (R)

Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.

Rosa Rademakers (R)

Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, University of Antwerp, Antwerp, Belgium.

Cyril Pottier (C)

Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, University of Antwerp, Antwerp, Belgium.

Laura Donker Kaat (LD)

Department of Neurology & Alzheimer Center, Erasmus Medical Center, Rotterdam, the Netherlands; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.

Harro Seelaar (H)

Department of Neurology & Alzheimer Center, Erasmus Medical Center, Rotterdam, the Netherlands.

John C van Swieten (JC)

Department of Neurology & Alzheimer Center, Erasmus Medical Center, Rotterdam, the Netherlands.

Elise G P Dopper (EGP)

Department of Neurology & Alzheimer Center, Erasmus Medical Center, Rotterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH